Related Experiment Videos
Directed migration of circulating polymorphonuclear leucocytes in patients with rheumatoid arthritis: a defect in the
Abstract:
The migration of peripheral polymorphonuclear leucocytes (PMNs) of patients with rheumatoid arthritis has been studied both in vivo and in vitro. A significant reduction in the accumulation of PMNs in skin chambers in patients with rheumatoid arthritis compared to controls was observed but no defect in cell movement was detected when the isolated PMNs from the patients were exposed to activated control plasma. However, when PMNs from the control group were tested against activated plasma from patients with rheumatoid arthritis there was a significant decrease in their chemotactic response. It is proposed that there is a humoral defect in the plasma of the patients.
Insights
Rheumatoid arthritis patients show reduced polymorphonuclear leucocyte (PMN) accumulation in vivo. In vitro studies suggest a plasma defect, not a PMN defect, contributes to impaired immune cell migration in rheumatoid arthritis.
Area of Science:
- Immunology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint inflammation and potential systemic effects.
- Polymorphonuclear leucocytes (PMNs) play a crucial role in the inflammatory response.
- Understanding PMN function in RA is vital for developing targeted therapies.
Purpose of the Study:
- To investigate the in vivo and in vitro migration of peripheral PMNs in patients with rheumatoid arthritis (RA).
- To determine whether defects in PMN function or plasma factors contribute to altered immune cell behavior in RA.
Main Methods:
- In vivo study using skin chambers to assess PMN accumulation in RA patients versus controls.
- In vitro assessment of isolated PMN chemotaxis towards activated plasma from both RA patients and controls.
Main Results:
- A significant reduction in PMN accumulation was observed in skin chambers of RA patients compared to controls.
- Isolated PMNs from RA patients did not show impaired movement when exposed to activated control plasma.
- PMNs from control individuals exhibited significantly decreased chemotaxis when exposed to activated plasma from RA patients.
Conclusions:
- The findings suggest a humoral defect within the plasma of RA patients is responsible for the observed impairment in PMN migration.
- This humoral defect in RA plasma likely contributes to the reduced inflammatory cell infiltration seen in the disease.
- Further research into plasma-derived factors in RA is warranted to elucidate the specific defect.